SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-029211
Filing Date
2009-08-04
Accepted
2009-08-04 07:00:30
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b76204e10vq.htm 10-Q 367183
2 EX-31.1 SECTION 302 CERTIFICATION OF CEO b76204exv31w1.htm EX-31.1 5956
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO b76204exv31w2.htm EX-31.2 6247
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO b76204exv32w1.htm EX-32.1 3209
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO b76204exv32w2.htm EX-32.2 2963
  Complete submission text file 0000950123-09-029211.txt   387050
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 09981629
SIC: 2836 Biological Products, (No Diagnostic Substances)